Business Standard
Friday, Feb 17, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Aurobindo gets USFDA nod for Cefotaxime injection
Press Trust of India / Mumbai Nov 09, 2009, 17:17 IST

Aurobindo Pharma today said it has got the final approval from the US drug regulator to market its antibiotic Cefotaxime injection used for treating various infections.

The company has received final approvals from the US Food & Drug Administration (USFDA) for two abbreviated new drug applications (ANDAs)--Cefotaxime for Injection in the strength of 1g, 2g and Cefotaxime for Injection in 10g (pharmacy bulk pack) dose, Aurobindo Pharma said in a statement to the Bombay Stock Exchange (BSE).

BSE | NSE
Price  
aurobindo pharma
Cefotaxime is the generic version of global drug major Sanofi Aventis' Claforan injection.

The products are ready for launch, the Hyderabad-based drug maker said.

With these approvals, Aurobindo Pharma now has 109 ANDA approvals, which includes both tentative and final, from the USFDA.

Shares of Aurobindo Pharma today closed at Rs 819.30, up 0.33 per cent from its previous close on the BSE.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets glued to gains
- Shiv Sena-BJP alliance set to emerge largest bloc in BMC
- Markets trim gains on profit taking
- World stocks firm on Greek hopes, dollar up on data
- Copper recovers on global cues, up 0.4%
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- Save over Rs.3000 with IndianOil Citibank Card
- India's No. 1 Property Site. Click here to know more..
- Get 5% cashback on telephone bills with Citi
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Office 365 for professionals and small businesses.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- Marico: Stepping into unchartered territory
- Army to step up vigil in Uttarakhand
- MCX IPO to make staff millionaires
- Sonalde Desai: Sons of the soil
- Asian stocks fall as Greek bailout delay dampens mood
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only
  Buy Now
  Now available on the Kindle Store...
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us